SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 8.470-0.5%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred12/15/2010 1:04:31 PM
   of 6147
 
ETFs to Play Biotech M&A
By Kevin Grewal, Contributor 12/15/10 - 11:40 AM EST

This activity has been fueled by cash-heavy companies looking to diversify and broaden their horizons.

To put this into perspective, in just two days, nearly $3.1 billion in biotech-related deals were announced, and some suggest more activity is to come.

Big Pharma front-runners such as Pfizer(PFE_), Sanofi-Aventis(SNE_), Amgen(AMGN_) and Merck(MRK_) are expected to find themselves in something of a rut because of expiring patents and lackluster drug pipelines.

As a result, Big Pharma is likely to look at smaller, more nimble companies that are focusing on specific treatments and medical specialties.

Some ETFs that are likely to be influenced by this increased activity include:

* SPDR S&P Biotech ETF, which allocates nearly 51.5% of its assets to small-cap companies and 30.75% to medium-cap companies, which are the most susceptible to M&A activity.
* iShares Nasdaq Biotechnology ETF, which tracks big players like Amgen as well as small and mid-cap stocks that are prime targets for M&A.
* Biotech HOLDRs, which predominantly allocates its holdings to large-cap companies such as Amgen, Gilead Sciences(GILD_) and Biogen Idec Inc(BIIB_). These are the likely acquirers in the sector.
* iShares Dow Jones US Pharmaceuticals, which includes drug giants Pfizer and Merck among its top holdings.
thestreet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext